Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.49 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30368533 | 1.00 | LMNA (0.55) | LMNANPC1S1PR3NR5A1MAPT | |
| SCHEMBL30368396 | 0.98 | LMNA (0.56) | LMNANPC1S1PR3NR5A1MAPT | |
| SCHEMBL6765500 | 0.95 | NPC1 (0.56) | LMNANPC1S1PR3MAPTPKM | |
| SCHEMBL30368319 | 0.89 | MAPT (0.54) | LMNANPC1MAPTRAB9ACRBN | |
| SCHEMBL15740948 | 0.83 | LMNA (0.50) | LMNANPC1S1PR3NR5A1MAPT | |
| SCHEMBL30368557 | 0.83 | MAPT (0.52) | LMNANPC1MAPTTP53TSHR | |
| SCHEMBL16307340 | 0.81 | NR5A1 (0.58) | LMNAS1PR3NR5A1TP53TSHR | |
| SCHEMBL7004191 | 0.81 | CRBN (0.55) | LMNANPC1S1PR3MAPTPKM | |
| SCHEMBL7005119 | 0.81 | CRBN (0.55) | LMNANPC1S1PR3MAPTPKM | |
| SCHEMBL12676595 | 0.80 | MAPT (0.62) | LMNAMAPTPKMTP53RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509579-B2 | Thermoplastic resin and optical lens including same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-12-30 | — | — | US | disclosed |
| CN-115996931-B | Cyclic diol compound, process for producing the compound, and use of the compound | 新日本理化株式会社 | 2025-04-01 | — | — | CN | disclosed |
| US-20230399510-A1 | THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-12-14 | — | — | US | disclosed |
| EP-4239010-A1 | THERMOPLASTIC RESIN AND OPTICAL LENS INCLUDING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-09-06 | — | — | EP | disclosed |
| CN-116323753-A | Thermoplastic resin and optical lens comprising the same | 三菱瓦斯化学株式会社 | 2023-06-23 | — | — | CN | disclosed |
| CN-115996931-A | Cyclic diol compound, process for producing the compound, and use of the compound | 新日本理化株式会社 | 2023-04-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509579-B2 | Thermoplastic resin and optical lens including same | RIF1, POT1, LAS1L | LMNA 3247/4885NPC1 2774/4885S1PR3 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.